Literature DB >> 2914759

Optic disc cupping: four year follow-up from the WESDR.

B E Klein1, S E Moss, Y L Magli, R Klein, C Hoyer, J Johnson.   

Abstract

Change in optic disc cupping was evaluated in a 4-year follow-up of a well defined cohort of people with diabetes mellitus. Cup-to-disc ratios were computed for both vertical and horizontal diameters of each eye at the baseline and 4-year follow-up examinations. Graders were masked as to the identity of participants and to the dates of the photographs. Increases of at least 0.1 between baseline and follow-up were used as clinically significant change in the ratios. None of the following factors at baseline were consistent predictors of such a change: intraocular pressure, age, duration of diabetes, hypertension or severity of diabetic retinopathy. People who developed proliferative retinopathy by the follow-up examination were not more likely to have such an increase in ratio at the follow-up. We conclude that clinically significant increases in cup-to-disc ratio cannot be consistently predicted in people with diabetes from the risk factors evaluated with the grading system used in this study.

Entities:  

Mesh:

Year:  1989        PMID: 2914759

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

Review 1.  Distribution of intraocular pressure in healthy Iranian individuals: the Tehran Eye Study.

Authors:  H Hashemi; A H Kashi; A Fotouhi; K Mohammad
Journal:  Br J Ophthalmol       Date:  2005-06       Impact factor: 4.638

2.  Morphologic assessment for glaucoma in the Multicenter Uveitis Steroid Treatment (MUST) trial.

Authors:  Sapna S Gangaputra; Michael M Altaweel; Qian Peng; David S Friedman; P Kumar Rao; C Stephen Foster; Rosa Y Kim; Susan B Reed; Sunil K Srivastava; Ira G Wong; John H Kempen
Journal:  Ocul Immunol Inflamm       Date:  2011-08       Impact factor: 3.070

3.  Optic disc morphology in diabetes mellitus.

Authors:  K A Königsreuther; J B Jonas
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1995-04       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.